Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...
Biogen reported mixed results from a mid-stage clinical trial investigating a treatment for Alzheimer’s disease that targets ...
Regenxbio said its experimental gene therapy for Duchenne muscular dystrophy succeeded in a trial, paving the way for a ...
Leaders want the next FDA commissioner to be someone who can rebuild trust, focus on food policy, and drive drug-approval ...
Kyle Diamantas, the acting commissioner of the FDA, is expected to be a drama-free, stabilizing caretaker at the top of the ...
The next FDA leader, how the CDC is responding to hantavirus, and more health news from Morning Rounds ...
Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...
Tara Bannow covers hospitals, providers, and insurers. You can reach Tara on Signal at tarabannow.70. Bob Herman covers health insurance, government programs, hospitals, physicians, and other ...
Despite rising concern about the hantavirus outbreak on a cruise ship, two CDC doctors say the risk to the public remains low ...
Isabella is a chronic disease reporter writing about how the Trump administration is tackling the nation’s health epidemic — or not. You can reach her on Signal at isabellacueto.03. Robert F. Kennedy ...
Arriving in the isolation ward of a biocontainment hospital is an unsettling, scary experience. In 2014, I spent 19 days in ...
Officials say $1.3 billion in Medicaid money to California will be deferred over suspicions of fraud
Vice President JD Vance announced a $1.3 billion deferral in Medicaid reimbursements to California, as part of an initiative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results